Ulcer Clinical Trial
— ULCEREMIXTEOfficial title:
Effects of Compression in Mixed Ulcers
About 15% to 30% of patients with venous leg ulcers have a peripheral arterial disease (PAD)
associated. The compression band is still a controversial issue in this context. It allows
the reduction of venous hypertension and edema, but it could potentially degrade the
arterial infusion of high levels of compression. The French High Authority for Health (HAS)
defines mixed ulcers by IPS between 0.5 and 0.9. Investigators distinguish mixed ulcers
blood predominance for IPS between 0.5 and 0.7; and mixed ulcers predominantly venous blood
with moderate involvement for IPS values between 0.7 and 0.9.
Several studies have shown that IPS> 0.8 allowed a high compression, between 30 and 40 mmHg.
In the case of mixed ulcers with IPS between 0.6 and 0.8, the HAS recommends using a lighter
compression, bit by elastic bands (exercising low power compression at rest) under medical
supervision, informing the patient to remove the bandage if pain or aggravation. It is
therefore necessary to adapt the compression therapy in case of venous ulcers associated
with arterial disease by providing a lower compression 30 mmHg short stretch. For HAS, IPS
<0.6 against indicates compression.
A recent study showed that compression bit elastic bands could not only improve venous
return, but it would also increase the distal arterial flow in a patient population with
mixed ulcers. In this study, 25 patients had between IPS 0.5 and 0.8; or for certain
patients below the threshold of 0.6 indicates that against a compression according to HAS.
To our knowledge this is the only study that has examined the effect of compression on blood
perfusion.
Status | Completed |
Enrollment | 25 |
Est. completion date | July 2016 |
Est. primary completion date | July 2016 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
The mixed origin of the ulcer is defined by a venous disease (reflux in the superficial
veins and / or deep) and a moderate arterial disease, defined by: Inclusion Criteria: - A IPS 0.5 and 0.9, with a systolic pressure at the ankle> 70 mmHg - A big toe pressure index (IPGO) <0.7, with a systolic pressure of the big toe (PGO)> 50 mmHg Exclusion Criteria: - Topics aged under 18, - A normal IPS that is to say between 0.9 and 1.3, a critical ischemia (defined as ankle pressure <70 mmHg and / or systolic pressure of the big toe <50 mmHg) - Presence of peripheral neuropathy, - Presence of heart failure, - Refusal to participate in the study or to sign the consent, - Impaired cognitive function not to participate in a clinical study. |
Observational Model: Cohort, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
France | Groupe Hospitalier Paris Saint Joseph | Paris | Ile-de-France |
Lead Sponsor | Collaborator |
---|---|
Groupe Hospitalier Paris Saint Joseph |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Assessment of change of pain numeric scale | Day 1, just before the exam, 10minutes after the exam and 24 hours after the exam | No | |
Secondary | Assessment of change of distal arterial pressures of the compression carrier leg | Day 1, just before the exam, 10minutes after the exam and 24 hours after the exam | No | |
Secondary | Assessment of change of IPS (systolic pressure index) ankle pressures | Day 1, just before the exam, 10minutes after the exam and 24 hours after the exam | No | |
Secondary | Assessment of change of pressure exerted by low elastic bandage | Measuring pressure exerted by low elastic bandages by Kikuhime® system. | Day 1, just before the exam, 10minutes after the exam and 24 hours after the exam | No |
Secondary | Assessment of IPS (systolic pressure index) arm pressures | Day 1, just before the exam, 10minutes after the exam and 24 hours after the exam | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT02565264 -
Effect of Plasma Derived Exosomes on Cutaneous Wound Healing
|
Early Phase 1 | |
Recruiting |
NCT00926809 -
H. Pylori Eradication on Healing of Iatrogenic Gastric Ulcer by Endoscopic Mucosal Resection
|
Phase 4 | |
Completed |
NCT00633035 -
Comparison of Esomeprazole and Famotidine for Stress Ulcer Prophylaxis in Neurosurgical Intensive Care Unit
|
Phase 4 | |
Completed |
NCT00402727 -
Comparison of Sequential IV/PO Moxifloxacin With IV Piperacillin/Tazobactam Followed by PO Amoxicillin/Clavulanic Acid in Patients With a Complicated Skin and Skin Structure Infection
|
Phase 3 | |
Completed |
NCT06464250 -
The Effect of Bundle Approach on Foot Care Behaviors and Diabetic Wound Healing in Patients
|
N/A | |
Not yet recruiting |
NCT03250533 -
Analysis of the Effects of LED Phototherapy and Electrical Stimulation in the Healing of Diabetic Ulcers
|
N/A | |
Terminated |
NCT01657318 -
Olivamine-containing Products in the Management of Patients With Nonhealing Lower Extremity Ulcers
|
||
Completed |
NCT02535481 -
Epidermal Grafting in Wound Healing
|
N/A | |
Withdrawn |
NCT01215058 -
Gastroprotective Agent Compliance in Patients at Risk Suffering From a Gastrointestinal(GI) Ulcer
|
N/A | |
Recruiting |
NCT04210089 -
Total Contact Soft Cast in Diabetic Foot Ulcers
|
N/A | |
Completed |
NCT04573959 -
Validation of CapsoVision CapsoCam® SV-3 Capsule Endoscopy System
|
N/A | |
Recruiting |
NCT03347812 -
Clinical Study for Evaluating the Safety and Efficacy of Total Endovascular Aortic Arch Repair
|
N/A | |
Active, not recruiting |
NCT02973893 -
Study of VF001-DP in Patients With Chronic Venous Leg Ulcers
|
Phase 2 | |
Terminated |
NCT01853384 -
Safety and Efficacy Trial of HP802-247 in the Treatment of Chronic Venous Leg Ulcers
|
Phase 3 | |
Completed |
NCT00221143 -
Stem Cell Study for Patients With Leg Ulcer/Gangrene
|
Phase 1/Phase 2 | |
Completed |
NCT00158483 -
Anti-Herpetic Treatment of Genital Ulcer : Effect on HIV & Herpes Shedding (ANRS 1212)
|
Phase 2 | |
Completed |
NCT00660049 -
Feasibility Study of a Novel Device for Chronic Wounds
|
N/A | |
Completed |
NCT00450216 -
Efficacy and Safety Study of HZT-501 in Subjects Requiring Nonsteroidal Anti-Inflammatory Drug (NSAID) Treatment
|
Phase 3 | |
Completed |
NCT00164424 -
Episodic Acyclovir Therapy for Genital Ulcers
|
Phase 2/Phase 3 | |
Completed |
NCT02733978 -
Ozone Therapy in the Treatment of Digital Ulcers in Patients With Systemic Sclerosis
|
N/A |